Source: Virtual Congress 2020 – Advances in lung function testing
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Radovanovic (Milano (MI), Italy), M. Pecchiari (Milano (MI), Italy), M. Saad (Milano (MI), Italy), P. Santus (Milano (MI), Italy). Closing volume predicts the FEV1 response to bronchodilators in patients with COPD. 3082

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids Source: Annual Congress 2006 - New features of paediatric asthma Year: 2006 Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Influence of basal FEV1 on the response to bronchodilator agents in COPD Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001 Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR® Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Tiotropium: COPD exacerbations and decline in FEV1 Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 Differentiation of bronchodilator effects of indacaterol and formoterol by FEV1 and inspiratory capacity (IC) in patients with COPD Source: Annual Congress 2007 - New drugs for COPD Year: 2007 How often FEV1 underestimates bronchodilator response? Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003 Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV1) in patients with severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Respiratory structure and function Year: 2008 FEV1 and MRI ventilation defect reversibility in asthma and COPD Source: Eur Respir J, 55 (3) 1901947; 10.1183/13993003.01947-2019 Year: 2020 Postbronchodilator response of small airways after 800 microgrammes of salbutamol in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Improvement in FEV1 after acute COPD exacerbations are driven more by changes in hyperinflation than changes in proximal airway volume Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease Year: 2015 The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation Source: Annual Congress 2007 - New drugs for asthma Year: 2007 Frequency of acute flow and volume responses to bronchodilator administration in patients with COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 Basal FEV1 does not predict the long term response to salmeterol/fluticasone in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004 Improvements in inspiratory capacity with tiotropium in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 491s Year: 2002 Changes in lung function in patients with acute COPD exacerbations: spirometry vs. forced oscillations Source: Eur Respir J 2001; 18: Suppl. 33, 149s Year: 2001 Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013